Fact CheckerSign in

NCT06322771Completed

Women's Refusal to Participate in a Randomized Trial Involving First-trimester Screening for Pre-eclampsia: Factors Associated With Refusal and Reasons for Acceptance and Refusal

Source: ClinicalTrials.gov · Last updated 15 Sept 2025

Brief summary (registry, in English)

The main objective is to assess whether there are factors associated with women's refusal to participate in a randomized clinical trial involving first-trimester screening for pre-eclampsia. The secondary objective is to qualitatively evaluate the reasons for acceptance and refusal to participate.

Status (registry)
Completed
Study type
Observational
Enrollment
472 (actual)
First submitted
14 Mar 2024
Start date
11 Apr 2024
Primary completion date
31 Oct 2024
Lead sponsor
Assistance Publique - Hôpitaux de Paris
NCT number
NCT06322771

What you commit to

  • Study type: Observational
  • Participants enrolled: 472
  • From 11 Apr 2024 to the primary completion date, 31 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • Any pregnant woman is eligible if:
  • monofetal pregnancy
  • between 11 and 14 weeks
  • legal age
  • health insurance coverage

Age in the registry: 18 years to - · Sex: Female

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Port-Royal Maternity
Coordinator of this site? Confirm its status
ParisFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.